13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001596452
Total reported value
$131.7M
$131.7M
44 檔
72.1%
The Q3 2025 SEC filing reveals that Sivik Global Healthcare LLC held a total portfolio value of $131.7M, covering 44 public equity positions.
In Q3 2025, Sivik Global Healthcare LLC displayed an active expansion posture, initiating 21 new positions and adding to 5 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 7.29% | — | — | |
| 2 | ✓ | Put - Spy 100 @ 645 Exp 10/31/2025 | Stock-Other | 5.81% | — | — | |
| 3 | ✓ | Put - Spy 100 @ 639 Exp 10/31/2025 | Stock-Other | 4.85% | — | — | |
| 4 | ✓ | Put - Spy 100 @ 659 Exp 10/31/2025 | Stock-Other | 4.85% | — | — | |
| 5 | ✓ | Put - Spy 100 @ 658 Exp 10/31/2025 | Stock-Other | 4.85% | — | — | |
| 6 | ✓ | Put - Spy 100 @ 660 Exp 11/21/2025 | Stock-Other | 4.85% | — | — | |
| 7 | ✓ | Put - Spy 100 @ 660 Exp 10/31/2025 | Stock-Other | 4.85% | — | — | |
| 8 | ✓ | Put - Spy 100 @ 655 Exp 10/31/2025 | Stock-Other | 4.85% | — | — | |
| 9 | ✓ | Put - Spy 100 @ 659 Exp 11/21/2025 | Stock-Other | 4.85% | — | — | |
| 10 | ✓ | Put - Spy 100 @ 635 Exp 10/31/2025 | Stock-Other | 4.85% | — | — | |
| 11 | LLY | Eli Lilly & Co | Stock-Healthcare | 2.22% | — | -9.09% | |
| 12 | HCA | Hca Healthcare Inc | Stock-Healthcare | 2.11% | — | -32.00% | |
| 13 | THC | Tenet Healthcare CORP | Stock-Healthcare | 2.07% | — | -58.82% | |
| 14 | DHR | Danaher CORP | Stock-Healthcare | 2.02% | — | -12.50% | |
| 15 | BSX | Boston Scientific CORP | Stock-Healthcare | 1.99% | — | -12.50% | |
| 16 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 1.98% | — | — | |
| 17 | HUM | Humana Inc | Stock-Healthcare | 1.89% | — | -7.41% | |
| 18 | COR | Cencora Inc | Stock-Healthcare | 1.82% | — | -20.00% | |
| 19 | CAH | Cardinal Health Inc | Stock-Healthcare | 1.71% | — | -16.67% | |
| 20 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 1.69% | — | — | |
| 21 | SNN | Smith & Nephew PLC -spon Adr | Stock-Other | 1.69% | — | +14.29% | |
| 22 | UHS | Universal Health Services-b | Stock-Healthcare | 1.67% | — | -46.67% | |
| 23 | MDT | Medtronic plc | Stock-Healthcare | 1.66% | — | -25.00% | |
| 24 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 1.60% | — | — | |
| 25 | MCK | Mckesson CORP | Stock-Healthcare | 1.57% | — | -46.15% | |
| 26 | ABT | Abbott Laboratories | Stock-Healthcare | 1.46% | — | -4.34% | |
| 27 | SYK | Stryker CORP | Stock-Healthcare | 1.40% | — | -31.58% | |
| 28 | SGRY | Surgery Partners Inc | Stock-Other | 1.39% | — | +76.00% | |
| 29 | JNJ | Johnson & Johnson | Stock-Healthcare | 1.35% | — | — | |
| 30 | ABBV | Abbvie Inc | Stock-Healthcare | 1.35% | — | — | |
| 31 | EHC | Encompass Health CORP | Stock-Healthcare | 1.29% | — | +40.00% | |
| 32 | A | Agilent Technologies Inc | Stock-Healthcare | 1.23% | — | -26.67% | |
| 33 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 1.21% | — | -20.00% | |
| 34 | CI | THE Cigna Group | Stock-Healthcare | 1.17% | — | -15.15% | |
| 35 | ZBH | Zimmer Biomet Holdings Inc | Stock-Healthcare | 1.15% | — | — | |
| 36 | WST | West Pharmaceutical Services | Stock-Healthcare | 1.14% | — | — | |
| 37 | DGX | Quest Diagnostics Inc | Stock-Healthcare | 1.11% | — | -20.00% | |
| 38 | RGEN | Repligen CORP | Stock-Healthcare | 1.07% | — | -8.33% | |
| 39 | BIO | Bio-rad Laboratories-a | Stock-Healthcare | 0.90% | — | -38.89% | |
| 40 | LH | Labcorp Holdings Inc | Stock-Healthcare | 0.84% | — | — | |
| 41 | SEM | Select Medical Holdings CORP | Stock-Other | 0.65% | — | -41.67% | |
| 42 | STVN | Stevanato Group S.p.A. | Stock-Other | 0.64% | — | — | |
| 43 | BRKR | Bruker CORP | Stock-Healthcare | 0.57% | — | — | |
| 44 | GEHC | GE Healthcare Technology | Stock-Healthcare | 0.55% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SNN | Smith & Nephew PLC -spon Adr | -0.2% | +14.29% | Add |
| 2 | UNH | Unitedhealth Group Inc | -0.2% | -20.00% | Add |
| 3 | SGRY | Surgery Partners Inc | -0.2% | +76.00% | Add |
| 4 | WST | West Pharmaceutical Services | -0.4% | — | Add |
| 5 | SEM | Select Medical Holdings CORP | -1.2% | -41.67% | Trim |
| 6 | HUM | Humana Inc | -1.4% | -7.41% | Add |
| 7 | EHC | Encompass Health CORP | -1.5% | +40.00% | Trim |
| 8 | UHS | Universal Health Services-b | -1.6% | -46.67% | Trim |
| 9 | ABT | Abbott Laboratories | -1.8% | -4.34% | Trim |
| 10 | DHR | Danaher CORP | -1.9% | -12.50% | Unchanged |
| 11 | A | Agilent Technologies Inc | -1.9% | -26.67% | Trim |
| 12 | COR | Cencora Inc | -1.9% | -20.00% | Trim |
| 13 | MDT | Medtronic plc | -2% | -25.00% | Trim |
| 14 | CAH | Cardinal Health Inc | -2% | -16.67% | Trim |
| 15 | ISRG | Intuitive Surgical Inc | -2.1% | — | Trim |
| 16 | SYK | Stryker CORP | -2.1% | -31.58% | Trim |
| 17 | MCK | Mckesson CORP | -2.4% | -46.15% | Trim |
| 18 | HCA | Hca Healthcare Inc | -2.6% | -32.00% | Trim |
| 19 | THC | Tenet Healthcare CORP | -3% | -58.82% | Trim |
| 20 | BSX | Boston Scientific CORP | -3.5% | -12.50% | Trim |
| 21 | XBI | Ss Spdr S&p Biotech ETF | -3.7% | — | Unchanged |
| 22 | ✓ | Put - Spy 100 @ 645 Exp 10/31/2025 | — | NEW | New buy |
| 23 | ✓ | Put - Spy 100 @ 660 Exp 11/21/2025 | — | NEW | New buy |
| 24 | ✓ | Put - Spy 100 @ 659 Exp 11/21/2025 | — | NEW | New buy |
| 25 | ✓ | Put - Spy 100 @ 655 Exp 10/31/2025 | — | NEW | New buy |
| 26 | ✓ | Put - Spy 100 @ 639 Exp 10/31/2025 | — | NEW | New buy |
| 27 | ✓ | Put - Spy 100 @ 659 Exp 10/31/2025 | — | NEW | New buy |
| 28 | ✓ | Put - Spy 100 @ 660 Exp 10/31/2025 | — | NEW | New buy |
| 29 | ✓ | Put - Spy 100 @ 635 Exp 10/31/2025 | — | NEW | New buy |
| 30 | ✓ | Put - Spy 100 @ 658 Exp 10/31/2025 | — | NEW | New buy |
| 31 | TMO | Thermo Fisher Scientific Inc | — | NEW | New buy |
| 32 | WAT | Waters CORP | — | EXIT | Sold out |
| 33 | BAX | Baxter International Inc | — | EXIT | Sold out |
| 34 | VRTX | Vertex Pharmaceuticals Inc | — | NEW | New buy |
| 35 | AZNN | Astrazeneca Plc-spons Adr | — | EXIT | Sold out |
| 36 | NVO | Novo-nordisk A/s-spons Adr | — | EXIT | Sold out |
| 37 | JNJ | Johnson & Johnson | — | NEW | New buy |
| 38 | ABBV | Abbvie Inc | — | NEW | New buy |
| 39 | GILD | Gilead Sciences Inc | — | EXIT | Sold out |
| 40 | ZBH | Zimmer Biomet Holdings Inc | — | NEW | New buy |
| 41 | DGX | Quest Diagnostics Inc | — | NEW | New buy |
| 42 | RGEN | Repligen CORP | — | NEW | New buy |
| 43 | AVTR | Avantor Inc | — | EXIT | Sold out |
| 44 | BIO | Bio-rad Laboratories-a | — | NEW | New buy |
| 45 | LH | Labcorp Holdings Inc | — | NEW | New buy |
| 46 | STVN | Stevanato Group S.p.A. | — | NEW | New buy |
| 47 | BRKR | Bruker CORP | — | NEW | New buy |
| 48 | GEHC | GE Healthcare Technology | — | NEW | New buy |
| 49 | SRPT | Sarepta Therapeutics Inc | — | EXIT | Sold out |
| 50 | ✓ | Put - Spy 100 @ 570 Exp 04/17/2025 | — | EXIT | Sold out |
According to official SEC Form 13F filings, Sivik Global Healthcare LLC reported a total U.S. public equity portfolio value of $131.7M across 44 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including XBI, PUT - SPY 100 @ 645 EXP 10/31/2025, PUT - SPY 100 @ 639 EXP 10/31/2025) accounted for 72.1% of total reported equity market value during Q3 2025.
Top New Position Initiated
PUT - SPY 100 @ 645 EXP 10/31/2025
市值: $20.0M
Top Position Liquidated / Trimmed
WAT
前期市值: $6.3M
During Q3 2025, Sivik Global Healthcare LLC's top holdings by market value included XBI (7.3%)、PUT - SPY 100 @ 645 EXP 10/31/2025 (5.8%)、PUT - SPY 100 @ 639 EXP 10/31/2025 (4.8%). The largest single position, XBI, represented 7.3% of total portfolio value.
In Q3 2025, Sivik Global Healthcare LLC made 48 total portfolio adjustments, initiating 21 new buys, adding to 5 positions, trimming 14 holdings, and fully liquidating 8 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.